Journal article
Modeling combined radiopharmaceutical therapy: a linear optimization framework
Technology in cancer research & treatment, Vol.8(1), pp.51-60
02/2009
DOI: 10.1177/153303460900800107
PMID: 19166242
Abstract
In this paper, we investigate a previously proposed mathematical model describing the effects that an innovative combined radiopharmaceutical therapy might have on the delivery of radiation to the tumor and limiting critical organs. While focused on a specific dual agent therapy, this investigation will prove mathematically that for any two therapeutic radiopharmaceuticals with different limiting critical organs the model provides patient specific conditions under which combination therapy is superior to single agent therapy. In addition, this paper outlines general methods for calculating the amounts of administered radioactivity for each drug required to optimize tumor radiation dose. We also consider extensions of this model to include an arbitrary number of independent radiopharmaceuticals and/or other treatment factors.
Details
- Title: Subtitle
- Modeling combined radiopharmaceutical therapy: a linear optimization framework
- Creators
- Ian M Besse - University of IowaMark T Madsen - University of IowaDavid L Bushnell - University of IowaMalik E Juweid - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Technology in cancer research & treatment, Vol.8(1), pp.51-60
- DOI
- 10.1177/153303460900800107
- PMID
- 19166242
- NLM abbreviation
- Technol Cancer Res Treat
- ISSN
- 1533-0346
- eISSN
- 1533-0338
- Language
- English
- Date published
- 02/2009
- Academic Unit
- Radiology
- Record Identifier
- 9984318788102771
Metrics
14 Record Views